Scholar Rock Holding buy Piper Sandler
Start price
03.04.23
/
50%
€7.70
Target price
03.04.24
€23.86
Performance (%)
84.42%
End price
04.04.24
€14.20
Summary
This prediction ended on 04.04.24 with a price of €14.20. With a performance of 84.42% the BUY prediction by Piper_Sandler was a big success. Piper_Sandler has a follow-up prediction for Scholar Rock Holding where he still thinks Scholar Rock Holding is a Buy. Piper_Sandler has 50% into this predictionScholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Scholar Rock Holding | 0.719% | 0.719% | 91.781% |
| iShares Core DAX® | 0.476% | -0.039% | 13.342% |
| iShares Nasdaq 100 | 1.290% | 0.504% | 40.099% |
| iShares Nikkei 225® | 1.300% | -2.135% | 19.861% |
| iShares S&P 500 | 0.829% | 0.193% | 29.756% |
Comments by Piper_Sandler for this prediction
In the thread Scholar Rock Holding diskutieren
Scholar Rock Holding Co. (NASDAQ: SRRK) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $26.00 price target on the stock.
Ratings data for SRRK provided by MarketBeat
In the thread Trading Scholar Rock Holding
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Scholar Rock Holding
Scholar Rock Holding
Start price
Target price
Perf. (%)
€14.70
26.03.24
26.03.24
€25.79
26.03.25
26.03.25
-4.76%
06.05.24
06.05.24
